Upstream Bio, Inc.
UPB
Rank in Stocks
#16744
Upstream Bio, Inc. is a biotechnology company in the clinical development... Upstream Bio, Inc. is a biotechnology company in the clinical development stage, dedicated to innovating therapies for inflammatory conditions, particularly those affecting the severe respiratory system. Its pipeline notably features verekitug, a monoclonal antibody designed to selectively target and suppress the thymic stromal lymphopoietin receptor. Beyond this, the company is actively developing treatments for severe asthma, chronic rhinosinusitis with nasal polyps, and chronic obstructive pulmonary disease. Established in 2021, Upstream Bio maintains its operational base in Waltham, Massachusetts.
Share Price
$3.58
Last synced: 2026-11-09
Market Cap
$196.08M
Change (1 day)
10.84%
Change (1 year)
-84.91%
Country
Stock data: Financial Modeling PrepยทUpdated ยทNot investment adviceยทHow we calculate this
Trade Upstream Bio, Inc. (UPB)
Category
Healthcare
EPS for Upstream Bio, Inc. (UPB)
EPS as of June 2026 TTM: $-2.90
According to Upstream Bio, Inc.'s latest financial reports, its current EPS (TTM) is $-2.90. At the end of 2025 the company had an EPS of $-2.66, a decrease compared to its 2024 EPS of $-1.49.
EPS history for Upstream Bio, Inc. from 2022 to 2026
EPS at the end of each year
| Year | EPS | Change |
|---|---|---|
| 2026 (TTM) | $-2.90 | 9.02% |
| 2025 | $-2.66 | 78.52% |
| 2024 | $-1.49 | 41.90% |
| 2023 | $-1.05 | 59.09% |
| 2022 | $-0.66 | 0.00% |
EPS for similar companies or competitors
| Company | EPS | EPS Difference | Country |
|---|---|---|---|
| $15.66 | -640.00% |
US
|
|
| $-7.07 | 143.79% |
US
|
|
| $-5.29 | 82.41% |
AU
|
|
| $12.88 | -544.14% |
BE
|
|
| $21.56 | -843.45% |
NL
|
Questions about Upstream Bio, Inc.'s earnings per share (EPS)
What is Upstream Bio, Inc.'s earnings per share (EPS)?
Upstream Bio, Inc.'s earnings per share (EPS) over the last twelve months is $-2.90, as of Jun 2026.
What was Upstream Bio, Inc.'s earnings per share (EPS) in 2025?
In 2025, Upstream Bio, Inc.'s earnings per share (EPS) was $-2.66, compared with $-1.49 in 2024.
How has Upstream Bio, Inc.'s earnings per share (EPS) changed since 2022?
From 2022 to 2025, Upstream Bio, Inc.'s earnings per share (EPS) was highest in 2022 ($-0.66) and lowest in 2025 ($-2.66).
How does Upstream Bio, Inc.'s earnings per share (EPS) compare with similar companies?
Upstream Bio, Inc.'s earnings per share (EPS) ($-2.90) is higher than that of 2 of the 5 similar companies listed above. The highest among them is Argenx SE, with $21.56.